Neonatal Abstinence Syndrome
NEJM 375:2468-2479, McQueen, K. & Murphy-Oikonen, J., 2016
Cannabis-Related Disorders and Toxic Effects
NEJM 389: 2267-2275, Gorelick,D.A., 2023
Prevalence of Cannabis Withdrawal Symptoms Among People with Regular or Dependent Use of Cannabinoids
JAMA doi:10.1001/JAMANETWORKOPEN.2020.2370, Bahji, A.,et al, 2020
Neonatal Abstinence Syndrome
JAMA 319:1362-1374, Wachman, E.,et al, 2018
Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome
NEJM 376:2341-2348, Kraft, W.K.,et al, 2017
A 62-Year-Old Woman with Bizarre Behavior and Recurrent Episodes of Behavioral Arrest
Neurol 86:e62-e65, Briglia, H.,et al, 2016
Myasthenia Gravis Exacerbation after Discontinuing Mycophenolate
Neurol 86:1159-1163, Oskarsson, B.,et al, 2016
Withdrawing Amantadine in Dyskinetic Patients with Parkinson Disease
Neurol 82:300-307, Ory-Magne, F.,et al, 2014
Recognition and Management of Withdrawal Delirium
NEJM 371:2109-2113, Schuckit, M.A., 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Opiates and Synthetic Analgesic Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1201, Ropper, A.H.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Sedative-Hypnotic Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1206, Ropper, A.H.,et al, 2014
Clinical Features of Dopamine Agonist Withdrawal Syndrome in a Movement Disorders Clinic
JNNP 84:130-135, Pondal, M.,et al, 2013
Serotonin Syndrome Associated with Clozapine Withdrawal
JAMA Neurol 70:1054-1055, Stevenson, E.,et al, 2013
Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012
"Bath Salts" Intoxication
NEJM 365:967-968, Ross, E.A.,et al, 2011
Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Arch Neurol 67:58-63, Rabinak,C. &Nirenberg,M., 2010
Neuromuscular Symptoms and Elevated Creatine Kinase After Statin Withdrawal
NEJM 362:564-565, Echaniz-Laguna,A.,et al, 2010
Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008
Generalized Tonic-Clonic Seizures After Acute Oxcarbazepine Withdrawal
Neurol 70:2187-2188, Azar,N.J.,et al, 2008
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
Probably Medication-Overuse Headache: The Effect of a 2-Month Drug-Free Period
Neurol 66:1894-1898, Zeeberg,P.,et al, 2006
The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005
Transient Lesion in the Splenium of the Corpus Callosum and Antiepileptic Drug Withdrawal
Neurol 65:1032-1036, Gurtler,S.,et al, 2005
Agitation by Sedation
Lancet 361:308, Tuohy,K.A.,et al, 2003
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Intrathecal Baclofen for Stiff-Person Syndrome: Life-Threatening Intermittent Catheter Leakage
Neurol 60:1976-1978, Bardutzky,J.,et al, 2003
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003
Intrathecal Baclofen Withdrawal Mimicking Sepsis
J Emerg Med 24:423-427, Kao,L.W.,e tal, 2003
Delirium From Nicotine Withdrawal in Neuro-ICU Patients
Neurol 57:551-553, Mayer,S.A.,et al, 2001
Clinical Features of Withdrawal Headache Following Overuse of Triptans and Other Headache Drugs
Neurol 57:1694-1698, Katsarava,Z.,et al, 2001
Clinical Benefits of Donepezil:Results from a Long-Term Phase III Extension Trial
Neurol 52:A174, Doody,R.S.,et al, 1999
Brief Antiepileptic Drug Withdrawal Prolongs Interval To Next Seizure
Neurol 53:1736-1741, Laowattana,S.,et al, 1999
A 24-Week, Double-Blind, Placebo-Controlled Trial of Donepezil in Pts with Alzheimer's Disease
Neurol 50:136-145, Rogers,S.,et al, 1998
Donepezil Improves Cognition & Global Function in Alzheimer Dis, 15-Week Doub-Blind, Plac-Contr Study
Arch Int Med 158:1021-1031, 9411998., Rogers,S.L.,et al, 1998
Acute Delirium After Withdrawal of Amantadine in Parkinson's Disease
Neurol 50:1456-1458, Factor,S.A.,et al, 1998
Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
Medical Causes of Seizures
Lancet 352:383-390, Delanty,N.,et al, 1998
Trihexyphenidyl Withdrawal Encephalopathy
Ann Neurol 41:133-134, Johkura,K.,et al, 1997
Easy Therapeutical Management of Sumatriptan-Induced Daily Headache
Neurol 47:297-298, Gobel,H.,et al, 1996
Status Epilepticus Induced by Felbatol Withdrawal
Neurol 45:1021-1022, DeGiorgio,C.M.,et al, 1995
Chronic headache:Appropriate Use of Opiate Analgesics
Neurol 44:S18-S24, Markley,H.G., 1994
Discontinuing Antiepileptic Drugs in Children with Epilepsy
NEJM 330:1407-1410, Tennison,M.,et al, 1994
Discontinuing Antiepileptic Drugs in Children with Epilepsy:A Prospective Study
Ann Neurol 35:534-545, 5091994., Shinnar,S.,et al, 1994
Spasmodic Torticollis Occurring During Alcohol Withdrawal
Neurol 43:623-624, DeKeyser,J., 1993
Withdrawal of Antiepileptic Medication in Children-Effects of Congit Funct Multicenter Holmfrid Study
Aldenkamp. A. P. , et al, neurol 43:41-50., , 1993
Use of Benzodiazepines in Anxiety Disorders
NEJM 328:1398-1405, Shader,R.I.&Greenblatt,D.J., 1993
Carbamazepine Withdrawal:Effects of Taper Rate on Seizure Frequency
Neurol 43:2280-2284, Malow,B.A.,et al, 1993
Prolonged Seizure Activity after Baclofen Withdrawal
Neurol 42:697-698, Kofler,M.&Leis,A.A., 1992
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992